Eli Lilly suing GLP1 compounders & related companies
Eli Lilly sues many compounding-related companies in an effort to clear the market of compounded GLP1.
Compounding GLP1s is now almost effectively a thing of the past. Companies like HIMS which heavily depended on compounding for cheap supply of GLP1s no longer offer it as an option:
HIMS ends compounded Semaglutide offering
Hims announces it will stop providing compounded Semaglutide, after removal from the FDA shortage list.
GLP1.Guide Staff
Eli Lilly is taking this one step further and suing many corporations involved GLP1 compounding, including some TeleHealth providers:
- Aios Inc
- Capitol Contours
- Houston Weight Loss Centers of Texas
- Cleveland Health Group
- Lucy’s Laser & MedSpa
- Aequita Corporation
- Willow Health Services
- Adonis Health
The rest of this article is no longer available for free – if you'd like to read the rest of our analysis, check us out on Substack:
